News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,160 Results
Type
Article (3122)
Company Profile (53)
Press Release (92985)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (36407)
Career Advice (67)
Deals (6053)
Drug Delivery (11)
Drug Development (12544)
Employer Resources (10)
FDA (2470)
Job Trends (2358)
News (55747)
Policy (3691)
Tag
2027 Genetown Elite (1)
Academia (245)
Accelerated approval (5)
Adcomms (2)
Allergies (28)
Alliances (4479)
ALS (12)
Alzheimer's disease (244)
Antibody-drug conjugate (ADC) (52)
Approvals (2583)
Artificial intelligence (42)
Autoimmune disease (12)
Automation (2)
Bankruptcy (36)
Best Places to Work (2123)
BIOSECURE Act (1)
Biosimilars (17)
Biotechnology (39)
Bladder cancer (41)
Brain cancer (4)
Breast cancer (116)
Cancer (744)
Cardiovascular disease (79)
Career advice (62)
CAR-T (20)
CDC (10)
Cell therapy (74)
Cervical cancer (6)
Clinical research (11496)
Collaboration (128)
Compensation (156)
Complete response letters (5)
COVID-19 (354)
CRISPR (8)
C-suite (40)
Cystic fibrosis (18)
Data (1075)
Depression (21)
Diabetes (77)
Diagnostics (992)
Digital health (12)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (19)
Drug pricing (18)
Drug shortages (1)
Duchenne muscular dystrophy (24)
Earnings (29877)
Editorial (3)
Employer resources (11)
Events (11732)
Executive appointments (47)
FDA (3135)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (8)
Funding (123)
Gene editing (19)
Generative AI (4)
Gene therapy (44)
GLP-1 (147)
Government (470)
Grass and pollen (2)
Guidances (278)
Healthcare (2691)
HIV (11)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (34)
Immuno-oncology (5)
Indications (20)
Infectious disease (414)
Inflammatory bowel disease (23)
Inflation Reduction Act (2)
Influenza (31)
Intellectual property (19)
Interviews (7)
IPO (3988)
IRA (2)
Job creations (339)
Job search strategy (55)
JPM (3)
Kidney cancer (5)
Labor market (11)
Layoffs (49)
Leadership (2)
Legal (635)
Liver cancer (11)
Longevity (1)
Lung cancer (111)
Lymphoma (107)
Machine learning (4)
Management (1)
Manufacturing (80)
MASH (34)
Medical device (2408)
Medtech (2414)
Mergers & acquisitions (2176)
Metabolic disorders (184)
Multiple sclerosis (35)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (9)
Neuroscience (401)
NextGen: Class of 2026 (719)
Non-profit (477)
Now hiring (2)
Obesity (71)
Opinion (13)
Ovarian cancer (34)
Pain (22)
Pancreatic cancer (22)
Parkinson's disease (33)
Partnered (1)
Patents (37)
Patient recruitment (59)
Peanut (12)
People (3869)
Pharmaceutical (8)
Pharmacy benefit managers (3)
Phase 1 (2808)
Phase 2 (4520)
Phase 3 (4812)
Pipeline (1600)
Policy (25)
Postmarket research (529)
Preclinical (840)
Press Release (2)
Prostate cancer (35)
Psychedelics (2)
Radiopharmaceuticals (37)
Rare diseases (91)
Real estate (535)
Recruiting (4)
Regulatory (3149)
Reports (15)
Research institute (230)
Resumes & cover letters (7)
Rett syndrome (1)
RNA editing (1)
RSV (18)
Schizophrenia (24)
Series A (20)
Series B (18)
Service/supplier (2)
Sickle cell disease (15)
Special edition (3)
Spinal muscular atrophy (23)
Sponsored (2)
Startups (357)
Stomach cancer (2)
Supply chain (7)
Tariffs (5)
The Weekly (3)
Vaccines (192)
Venture capital (5)
Weight loss (44)
Women's health (11)
Worklife (1)
Date
Today (3)
Last 7 days (80)
Last 30 days (282)
Last 365 days (4852)
2026 (476)
2025 (4925)
2024 (5973)
2023 (6901)
2022 (7874)
2021 (8607)
2020 (8086)
2019 (6487)
2018 (5251)
2017 (4745)
2016 (3726)
2015 (5211)
2014 (3479)
2013 (2303)
2012 (2473)
2011 (2867)
2010 (2429)
Location
Africa (80)
Alabama (10)
Arizona (49)
Asia (6047)
Australia (565)
California (2328)
Canada (363)
China (120)
Colorado (71)
Connecticut (60)
Delaware (101)
Europe (11962)
Florida (236)
Georgia (50)
Idaho (3)
Illinois (137)
India (7)
Indiana (106)
Japan (85)
Kansas (40)
Kentucky (7)
Louisiana (8)
Maine (12)
Maryland (222)
Massachusetts (1092)
Michigan (50)
Minnesota (147)
Mississippi (1)
Missouri (19)
Montana (3)
Nebraska (4)
Nevada (18)
New Hampshire (27)
New Jersey (568)
New York (351)
North Carolina (217)
Northern California (1457)
Ohio (36)
Oklahoma (2)
Oregon (2)
Pennsylvania (299)
Puerto Rico (2)
Rhode Island (1)
South America (123)
South Carolina (1)
Southern California (589)
Tennessee (48)
Texas (209)
United States (6569)
Utah (41)
Virginia (27)
Washington D.C. (5)
Washington State (140)
West Virginia (1)
Wisconsin (13)
96,160 Results for "65".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Marius Pharmaceuticals to Initiate Study Evaluating KYZATREX® (testosterone undecanoate) CIII Capsules in Men Ages 65–80
January 9, 2026
·
6 min read
Press Releases
AvantGuard Awarded $2.65 Million in NIH Grants to Advance Next-Generation Antimicrobial Technologies
November 4, 2025
·
1 min read
Press Releases
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
September 26, 2025
·
5 min read
Press Releases
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
November 14, 2025
·
4 min read
Press Releases
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas
September 23, 2025
·
6 min read
Press Releases
Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
November 27, 2025
·
5 min read
Press Releases
Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease
September 16, 2025
·
5 min read
Manufacturing
Lilly Unveils Second Facility in Manufacturing Push, Naming Texas as Site of New $6.5B Plant
Lilly expects to open 615 high-wage roles in Texas in connection with its new facility, plus around 4,000 construction roles.
September 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim
September 23, 2025
·
3 min read
Press Releases
I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares
August 4, 2025
·
5 min read
1 of 9,616
Next
